Hemcheck ensures that hemolyzed blood samples are quickly and easily detected at the time of sampling.

See full video


Services

Hemcheck contributes to better care flow, reduced costs and, above all, increased patient safety.

Read more

Our new business

Read more about the planned deal to acquire IP rights regarding iron succinate treatment of patients with heart failure, from Bio Vitos (SWE)

Read more

Investors

Hemcheck is listed on Nasdaq First North Growth Market. Are you interested in more financial information about the company?

Read more

The product concept

Hemcheck's business is based on the Helge product concept. The product concept consists of three different disposable tests, s-Test and bgs-Test for blood samples in blood gas syringes and v-Test for blood samples in test tubes, and a common reader that quickly and easily determines whether the blood sample is hemolyzed or not. An accessory screen can be connected to the reader to enable extraction of quantified free hemoglobin values. The aim is to find hemolyzed blood samples in a few seconds in connection with the blood-sampling or quantifying the amount of free hemoglobin in the blood.


About Hemcheck 2024

News and Press releases


Hemcheck takes next step through the transaction with Bio Vitos

2023-09-07

Read more...

Hemcheck conditionally approved for continued listing by Nasdaq and can complete the transaction with Bio Vitos

2023-08-28

Read more...

Hemcheck has received a first order from its distributor Astemed

2023-05-15

Read more...

Additional follow up order from the Foundation for Innovative New Diagnostics (FIND)

2023-04-26

Read more...

Hemcheck has received a first order from the university hospital Charité in Berlin

2023-04-05

Read more...

Events


Prenumerera på vårt nyhetsbrev


Jag accepterar hemcheck.com integritetsvillkor

Create your own

health economic analysis!